Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dyskinesia, Medication-Induced”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04470050
What this trial is testing

Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal

Who this might be right for
Opioid Withdrawal
BioXcel Therapeutics Inc 225
Testing effectiveness (Phase 2)Ended earlyNCT00686699
What this trial is testing

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Who this might be right for
Akathisia, Drug-InducedDyskinesia, Drug-InducedParkinsonian Disorders
Merck Sharp & Dohme LLC 11
Post-approval studies (Phase 4)Study completedNCT03681574
What this trial is testing

Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology

Who this might be right for
Pain, PostoperativeAgitation States as Acute Reaction to Exceptional StressAnesthesia+1 more
Hospital Infantil Albert Sabin 135
Post-approval studies (Phase 4)Study completedNCT03891862
What this trial is testing

Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia (TD)
Neurocrine Biosciences 135
Early research (Phase 1)Study completedNCT05238701
What this trial is testing

A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects

Who this might be right for
Huntington DiseaseTardive Dyskinesia
Luye Pharma Group Ltd. 104
Testing effectiveness (Phase 2)Study completedNCT01176721
What this trial is testing

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
cerbomed GmbH 20
Testing effectiveness (Phase 2)Ended earlyNCT00917293
What this trial is testing

Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Medicure 53
Large-scale testing (Phase 3)Study completedNCT00672373
What this trial is testing

Extract of Ginkgo Biloba and Tardive Dyskinesia

Who this might be right for
Tardive DyskinesiaSchizophrenia
Beijing HuiLongGuan Hospital 157
Not applicableNot Yet RecruitingNCT07715994
What this trial is testing

A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms

Who this might be right for
Extrapyramidal SymptomsDrug-induced ParkinsonismAkathisia, Drug-Induced+1 more
Shanghai Mental Health Center 180
Large-scale testing (Phase 3)WithdrawnNCT01908452
What this trial is testing

Pyridoxal Kinase Activity in Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Beersheva Mental Health Center
Large-scale testing (Phase 3)Study completedNCT00291213
What this trial is testing

Levetiracetam Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Yale University 50
Testing effectiveness (Phase 2)UnknownNCT04147949
What this trial is testing

AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia

Who this might be right for
Parkinson DiseaseDyskinesia, Medication-InducedL-Dopa Causing Adverse Effects in Therapeutic Use
VistaGen Therapeutics, Inc. 20
Not applicableStudy completedNCT04064294
What this trial is testing

Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-Induced
VA Office of Research and Development 93
Large-scale testing (Phase 3)Study completedNCT02198794
What this trial is testing

Reducing Involuntary Movements in Participants With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Auspex Pharmaceuticals, Inc. 343
Not applicableUnknownNCT02840760
What this trial is testing

Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.

Who this might be right for
Tardive Dyskinesia
Shanghai Mental Health Center 60
Not applicableLooking for participantsNCT05317390
What this trial is testing

Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia

Who this might be right for
DystoniaDrug Induced DystoniaParkinson Disease+8 more
Massachusetts Eye and Ear Infirmary 1,000
Early research (Phase 1)WithdrawnNCT05053321
What this trial is testing

Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazine

Who this might be right for
Tardive Dyskinesia
Yale University
Post-approval studies (Phase 4)Looking for participantsNCT07105111
What this trial is testing

Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Neurocrine Biosciences 100
Testing effectiveness (Phase 2)WithdrawnNCT00621634
What this trial is testing

Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Université de Montréal
Not applicableStudy completedNCT03497013
What this trial is testing

Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Suzhou Psychiatric Hospital 64
Next Page